Aptalis Pharma Us Inc

FDA Regulatory Profile

Aptalis Pharma Us Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 2 FDA inspections, and 2 compliance actions on record. Its most recent recall (F-1008-2013, Class II) was initiated on February 4, 2013.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
2
Compliance Actions
2

Recent Recalls

NumberClassProductDate
F-1008-2013Class IISourceCF(R) Pediatric Drops, Multivitamins with A, B, D, E and K Plus Zinc, 2 FL OZ. (60ML), NDC 662February 4, 2013